ARCHIVES

FDA Official Outlines agency’s Views On Efficacy Requirement

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Group Chairman Balk At Board’s Recommendations

February 15, 1980

Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds

July 3, 1992

DCPC Advisors Consider Asking DRG For Section On Prevention & Control

May 14, 1993

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

Exit Joseph Nevins: Duke’s Genomics Luminary Quietly Leaves

October 18, 2013

Also ASCO to release abstracts to members prior to annual meeting.

January 30, 2004